with drugs like CDK4/6 inhibitor Ibrance (palbociclib), PARP inhibitor Talzenna (talazoparib), hormonal therapy Aromasin (exemestane) and trastuzumab biosimilar Trazimera. That range also opens up ...
Today’s approval allows the drug to be marketed in the 28 member ... German Society of Haematology and Medical Oncology, said: “Trazimera has the potential to help many patients with HER2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback